Business Description
Innoveren Scientific Inc
NAICS : 541714
SIC : 2834
ISIN : US4041243076
Description
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.99 | |||||
14-Day RSI | 99.67 | |||||
3-1 Month Momentum % | 75 | |||||
12-1 Month Momentum % | 250 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -202.65 | |||||
OCF Margin % | -202.65 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IVRN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innoveren Scientific Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.453 | ||
| EPS (TTM) ($) | -4.33 | ||
| Beta | 849.3838 | ||
| 3-Year Sharpe Ratio | 0.59 | ||
| 3-Year Sortino Ratio | 267.07 | ||
| Volatility % | 262.84 | ||
| 14-Day RSI | 99.67 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0007 | ||
| 12-1 Month Momentum % | 250 | ||
| 52-Week Range ($) | 0.0002 - 0.0007 | ||
| Shares Outstanding (Mil) | 4.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Innoveren Scientific Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Innoveren Scientific Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.001:1 Stock Split | 2022-06-13 | 19.95 (+16.67%) |
Show
Entries
Innoveren Scientific Inc Frequently Asked Questions
What is Innoveren Scientific Inc(IVRN)'s stock price today?
The current price of IVRN is $0.00. The 52 week high of IVRN is $0.00 and 52 week low is $0.00.
When is next earnings date of Innoveren Scientific Inc(IVRN)?
The next earnings date of Innoveren Scientific Inc(IVRN) is .
Does Innoveren Scientific Inc(IVRN) pay dividends? If so, how much?
Innoveren Scientific Inc(IVRN) does not pay dividend.
Guru Commentaries on OTCPK:IVRN
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Innoveren Scientific Announces 510(k) Submission for SkinDisc(TM) Lite | 2024-03-06 | ||
| Innoveren Scientific Divests Device & Receives Capital Infusion | 2023-10-03 |
Articles on Innoveren Scientific Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers